...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis
【24h】

Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis

机译:尿8-oxodg升高的尿8-氧代纤维化在慢性Opisthorchiasis中吡喹酮治疗后相关

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies demonstrated that urinary 8-oxodG is a predictive biomarker for Opisthorchis viverrini (OV)-associated hepatobiliary disease (HBD) and cholangiocarcinoma (CCA). This study examined the effects of praziquantel treatment on the profile of urinary 8-oxodG in relation to HBD status. Infection with OV, levels of urinary 8-oxodG, and HBD status in terms of periductal fibrosis (PDF) assessed by abdominal ultrasonography (US) were monitored and compared in cohorts of participants in Khon Kaen, Thailand, before and 1 year after praziquantel treatment. Urinary 8-oxodG levels significantly decreased after treatment compared with the baseline level in OV-infected participants who had no HBD (PDF negative; PDF-ve) (N = 14). Levels of 8-oxodG were unchanged after treatment in OV-infected subjects (OV+ve) who had positive PDF (N = 52). Within the positive PDF (PDF+ve) group who became PDF-ve after treatment, there was no significant change in 8-oxodG levels between pre- and posttreatment (reversible PDF = 65.3%). In those who had persistent PDF+ve at both ultrasound sampling points, there was no significant difference in urinary 8-oxodG levels between pre- and posttreatment (persistent PDF = 34.6%). Based on a logistic regression model and receiver operation curve analysis, the increase of 8-oxodG levels was found to be associated with increasing risk of PDF. Measurement of urinary 8-oxodG and US increased the likelihood of discovering persistent PDF, which is a predictable condition for the patients at risk of OV-associated CCA. To identify high-risk individuals for CCA, it is useful to perform US in combination with urinary 8-oxodG measurement.
机译:以前的研究表明,尿8-oxodg是用于Opisthorchis viverrini(OV) - 分配的肝胆疾病(HBD)和胆管癌(CCA)的预测生物标志物。本研究检测了吡喹酮治疗对尿8-oxodg与HBD状态相关的影响。通过腹膜超声(US)评估的潜水纤维化(PDF)对患有ov,尿8-oxodg和HBD状态的感染,并将在Praziquantel治疗之前和1年之前进行了肺炎,泰国的参与者的队列。治疗后尿8-oxodg水平显着降低,与没有HBD的ov感染的参与者中的基线水平(PDF阴性; PDF-VE)(n = 14)。在具有阳性PDF的OV感染受试者(OV + VE)中治疗后,8-氧代的水平不变(n = 52)。在阳性PDF(PDF + ve)组内,在治疗后成为PDF-ve的组,预治疗和后处理之间的8-氧代水平没有显着变化(可逆PDF = 65.3%)。在持久性PDF + VE在超声取样点的人中,预治疗和后处理(持久性PDF = 34.6%)之间的尿8-氧代水平没有显着差异。基于Logistic回归模型和接收器操作曲线分析,发现8-氧代水平的增加与增加PDF的风险有关。测量尿8-氧代和美国增加了发现持久性PDF的可能性,这对于患者患者有可预测的病症,患有ob相关的CCA的风险。为了识别CCA的高风险个体,可以与尿8-氧代测量相结合使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号